Bucricaine

This classification denotes an anesthetic agent with the molecular formula C17H22N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HUC352BGYM, chemically known as 1,2,3,4-tetrahydro-n-butyl-9-acridinamine but generally known as bucricaine, which bears US NIH Compound Identifier 9423. European Medicines Agency schedules Bucricaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05951MIG. The term BUCRICAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). BUCRICAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bucricaine under HS 29339990 and SITC 51577. As of Q4 2014, BUCRICAINE remains the US FDA Preferred Term for this commodity. Bucricaine bears US NLM identifiers UMLS ID C2347225 and NCI Concept Code C72141. SMILES: N(C1C2CCCCC2NC2C1CCCC2)CCCC.